Cargando…
Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients – follow-up and clinical implications
BACKGROUND: An intrathecal polyspecific antibody response is a well known finding in multiple sclerosis. However, little is known about the evolution of intrathecal antibodies over time and their impact on the disease progress. Therefore, we focused in this study on the intrathecal polyspecific anti...
Autores principales: | Petereit, Hela-Felicitas, Reske, Dirk |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1173126/ https://www.ncbi.nlm.nih.gov/pubmed/15982411 http://dx.doi.org/10.1186/1743-8454-2-3 |
Ejemplares similares
-
Cerebrospinal fluid in multiple sclerosis
por: Rammohan, Kottil W.
Publicado: (2009) -
The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019) -
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients
with multiple sclerosis treated with high-efficacy disease-modifying
therapies
por: Petereit, Hela-Felicitas, et al.
Publicado: (2021) -
Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006) -
Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests()
por: Leinikki, Pauli, et al.
Publicado: (1982)